Beck Bode LLC Invests $17.26 Million in Cardinal Health, Inc. $CAH

Beck Bode LLC purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 125,276 shares of the company’s stock, valued at approximately $17,259,000. Cardinal Health comprises approximately 3.2% of Beck Bode LLC’s portfolio, making the stock its 9th biggest holding. Beck Bode LLC owned approximately 0.05% of Cardinal Health as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health in the 1st quarter valued at approximately $26,000. Tompkins Financial Corp grew its position in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock worth $34,000 after acquiring an additional 128 shares during the period. GW&K Investment Management LLC increased its stake in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after acquiring an additional 144 shares during the last quarter. Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health during the fourth quarter worth $36,000. Finally, NBC Securities Inc. purchased a new stake in Cardinal Health in the first quarter valued at $48,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of CAH opened at $149.39 on Thursday. The company’s 50-day simple moving average is $158.02 and its 200-day simple moving average is $145.75. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44. The stock has a market capitalization of $35.67 billion, a PE ratio of 23.16, a P/E/G ratio of 1.25 and a beta of 0.67.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Insiders Place Their Bets

In related news, insider Ola M. Snow sold 28,151 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares of the company’s stock, valued at $2,298,293.14. The trade was a 64.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the sale, the chief executive officer owned 200,000 shares in the company, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.09% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CAH. Bank of America increased their price target on Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, June 10th. Citigroup reaffirmed a “neutral” rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Robert W. Baird lifted their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Evercore ISI dropped their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.